NCT04824417View on ClinicalTrials.gov

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

PHASE3CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions

Chronic Pulmonary Aspergillosis

Interventions

DRUG

Itraconazole 200 mg

Control

DRUG

Voriconazole 200mg

Comparator

Trial Locations (2)

160012

Chest clinic, Chandigarh

Respiratory ICU, Department of Pulmonary Medicine, PGIMER, Chandigarh

All Listed Sponsors

lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT04824417 - A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis | Biotech Hunter | Biotech Hunter